Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE

Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE

Abstract Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.

Bibliographic Details
Main Authors: Shimalee Andarawewa, Emel Aygören‐Pürsün
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Clinical Case Reports
Subjects:
C1‐inhibitor concentrate
hereditary angioedema
lactation
pregnancy
prophylaxis
Online Access:https://doi.org/10.1002/ccr3.3743

Similar Items

Similar Items